February 6, 2019

The Early Diagnosis of Alzheimer’s Disease: Overcoming the Obstacles

International Conference on Alzheimer’s and Parkinson’s Disease 2020

Cognitive Differences between Subtypes of Alzheimer’s Disease

John Harrison, PhD, discusses the essential role of cognitive assessments in the diagnosis of Alzheimer’s disease. He describes the domains of cognition in Alzheimer’s disease and how these relate to the use of cognitive assessments for different subtypes of Alzheimer’s disease. He concludes by discussing the results of the comprehensive cognitive assessment from the patient case study.

Key Learning Objectives for Biogen’s AAT-AD/PD 2020 Symposium:

  • Understand the importance of an early diagnosis of Alzheimer’s disease
  • Assess the current healthcare system readiness for a paradigm shift to early diagnosis
  • Gain insights on how cognitive assessment tools and imaging biomarkers can be used to distinguish between different subtypes of Alzheimer’s disease
  • Increase understanding of the differences between the pathology of familial or sporadic early-onset and late-onset Alzheimer’s disease

Disclosure: All panelists received honoraria from Biogen for participation in this symposium.

Disclaimer: All of the information discussed today is for informational purposes only; does not constitute medical advice; and is not intended to be a substitute for independent professional medical judgment, advice, diagnosis, or treatment.